Scientists hunt for genetic clues to drug side effect in breast cancer
NCT ID NCT02610413
Summary
This study aims to understand why some breast cancer patients develop severe high blood pressure as a side effect of the drug bevacizumab. Researchers will analyze the DNA of 354 patients who either did or did not develop this side effect during a previous clinical trial. The goal is to find genetic markers that could predict a patient's risk, helping doctors manage treatment more safely.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Eastern Cooperative Oncology Group
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.